These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3494277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Biological exploration of Paget's disease (author's transl)].
    Nagant de Deuxchaisnes C, Rombouts-Lindemans C.
    J Belge Rhumatol Med Phys; 1974; 29(5-6):243-92. PubMed ID: 4470109
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [What do we know about the significance of vitamin D in Paget's disease of the bone?].
    Wilczek H, Stĕpán J, Justová V.
    Cas Lek Cesk; 1995 Dec 13; 134(24):785-7. PubMed ID: 8599821
    [Abstract] [Full Text] [Related]

  • 10. Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
    Singer FR, Clemens TL, Eusebio RA, Bekker PJ.
    J Clin Endocrinol Metab; 1998 Jun 13; 83(6):1906-10. PubMed ID: 9626117
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Biological and isotope explorations in Paget's disease of bone].
    Dell'Anno R, Eisinger J, Recordier AM.
    Rhumatologie; 1971 Apr 13; 23(4):119-39. PubMed ID: 4254981
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
    Charhon SA, Chapuy MC, Delvin EE, Meunier PJ.
    Miner Electrolyte Metab; 1985 Apr 13; 11(2):117-22. PubMed ID: 3838794
    [Abstract] [Full Text] [Related]

  • 16. [Bone mineral measurement in Paget's disease].
    Nuti R, Vattimo A.
    Boll Soc Ital Biol Sper; 1978 Jan 30; 54(2):141-5. PubMed ID: 737061
    [No Abstract] [Full Text] [Related]

  • 17. Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption.
    Chipman JJ, Zerwekh J, Nicar M, Marks J, Pak CY.
    J Clin Endocrinol Metab; 1980 Aug 30; 51(2):321-4. PubMed ID: 6249837
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA.
    Henry Ford Hosp Med J; 1983 Aug 30; 31(4):244-8. PubMed ID: 6425243
    [No Abstract] [Full Text] [Related]

  • 20. Long-term experience with a calcium-thiazide treatment for Paget's disease of bone.
    Evans RA, Dunstan CR, Wong SY, Hills E.
    Miner Electrolyte Metab; 1982 Dec 30; 8(6):325-33. PubMed ID: 7167138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.